Clinical trial registry record

Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase 2 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 26, 2019.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT00365794
Last registry update
August 26, 2019
Status
Completed
Phase
Phase 2
Sponsor
University of Southern California
Enrollment
22
Countries
United States
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 2
Study design
NA · SINGLE GROUP · TREATMENT · NONE
Evidence population
Human clinical study registration
Participants
22
Population
MALE · 60 Years to 90 Years
Duration
2006-08-01 to 2014-12-01
Intervention
Topical testosterone gel 10 g/day
Comparator
Not reported
Outcomes measured
Change in Total Mass and Regional Adipose Adiposiy — Baseline to 20 weeks; Change in Hepatic Lipid — Baseline to week 20; Intramyocellular Lipid (IMCL) — Baseline to week 20; Change in Percentage of Total Body Fat — Baseline and 20 weeks; Change in Total and Regional Carbohydrate Metabolism During a 2-hr Hyperinsulinemic Euglycemic Clamp and [6,6-2H2] Gluc…; Change in Skeletal Muscle Mass by DEXA — Baselne to 20 weeks; Plasma Lipids — Baseline to week 20; Change in HOMA-IR — Baseline to week 20; Change in Basal FFAs in Plasma — Baseline to week 20; Change in Plasma Free Fatty Acids During Glucose Clamp — Baseline to 20 weeks
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 2A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Lipid metabolism and ageing · 80%Title contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

lipid metabolism aging
Read the original source →Export JSON